Arecor Therapeutics (LSE:AREC) PB Ratio : 4.71 (As of May. 21, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Arecor Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-21), Arecor Therapeutics's share price is £1.465. Arecor Therapeutics's Book Value per Share for the quarter that ended in Dec. 2023 was £0.31. Hence, Arecor Therapeutics's PB Ratio of today is 4.71.

The historical rank and industry rank for Arecor Therapeutics's PB Ratio or its related term are showing as below:

LSE:AREC' s PB Ratio Range Over the Past 10 Years
Min: 3.2 Med: 4.56 Max: 150
Current: 4.71

During the past 7 years, Arecor Therapeutics's highest PB Ratio was 150.00. The lowest was 3.20. And the median was 4.56.

LSE:AREC's PB Ratio is ranked worse than
73.7% of 1323 companies
in the Biotechnology industry
Industry Median: 2.53 vs LSE:AREC: 4.71

During the past 12 months, Arecor Therapeutics's average Book Value Per Share Growth Rate was -45.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 123.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 76.80% per year.

During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Arecor Therapeutics was 202.80% per year. The lowest was 55.40% per year. And the median was 123.10% per year.

Back to Basics: PB Ratio

Arecor Therapeutics PB Ratio Historical Data

The historical data trend for Arecor Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arecor Therapeutics PB Ratio Chart

Arecor Therapeutics Annual Data

Trend

May17

May18

May19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

6.01

4.21

5.87

Arecor Therapeutics Semi-Annual Data
	May18	May19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
PB Ratio	Get a 7-Day Free Trial					6.01	6.39	4.21	5.34	5.87

Competitive Comparison of Arecor Therapeutics's PB Ratio

For the Biotechnology subindustry, Arecor Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arecor Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arecor Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Arecor Therapeutics's PB Ratio falls into.

Arecor Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Arecor Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	1.465	/	0.311
	=	4.71

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Arecor Therapeutics (LSE:AREC) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Arecor Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of Arecor Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Arecor Therapeutics (LSE:AREC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arecor Therapeutics PLC (LSE:AREC) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

6UI:Germany

Address

Chesterford Research Park, Little Chesterford, Saffron Walden, GBR, CB10 1XL

Website

https://www.arecor.com

Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying an innovative proprietary formulation technology platform, Aresta. It is developing a portfolio of proprietary products in diabetes and other indications and working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies. Geographically, it operates in the UK, Switzerland, the Rest of Europe, the USA, India, and the Rest of the World, out of which the majority is from the UK.